advansource biomaterials cor
(ASNB:OTC US)
advansource biomaterials cor (ASNB) Snapshot
|
Open
$0.08
|
Previous Close
$0.08
|
|
|
Day High
$0.08
|
Day Low
$0.06
|
|
|
52 Week High
10/1/12 - $0.13
|
52 Week Low
08/6/12 - $0.01
|
|
|
Market Cap
1.4M
|
Average Volume 10 Days
21.3K
|
|
|
EPS TTM
$-0.06
|
Shares Outstanding
21.5M
|
|
|
EX-Date
--
|
P/E TM
--
|
|
|
Dividend
--
|
Dividend Yield
--
|
Related News
advansource biomaterials cor (ASNB) Related Businessweek News
No Related Businessweek News Foundadvansource biomaterials cor (ASNB) Details
AdvanSource Biomaterials Corporation develops polymer materials for use in the design and development of medical devices for treating a range of anatomical sites and disease states. The company manufactures and sells custom polymers under the ChronoFilm, ChronoFlex, ChronoThane, ChronoPrene, ChronoSil, HydroThane, HydroMed, and PolyBlend trade names, as well as manufactures hydrophilic polyurethanes. It sells its polymers directly to customers in the United States. The company was formerly known as CardioTech International, Inc. and changed its name to AdvanSource Biomaterials Corporation in October 2008. AdvanSource Biomaterials Corporation was founded in 1993 and is headquartered in Wilmington, Massachusetts.
advansource biomaterials cor (ASNB) Top Compensated Officers
advansource biomaterials cor (ASNB) Key Developments
On January 11, 2013, AdvanSource Biomaterials Corporation based on the decision of the Audit Committee of its Board of Directors, dismissed Moody, Famiglietti & Andronico, LLP (MFA) as the company's independent registered public accounting firm and recommended, and approved, the engagement of Liggett, Vogt & Webb P.A. (LVW) to serve as the company's independent registered public accounting firm for the fiscal year ending March 31, 2013.
On 06/29/2012, AdvanSource Biomaterials Corporation announced that they will be unable to file their next 10-K by the deadline required by the SEC.
AdvanSource Biomaterials Corporation announced on June 20, 2012, Dr. Anthony J. Armini notified the board of directors that he would be retiring and resigning his position as a member of the board of directors effective form September 30, 2012.
| Recently Viewed | |||
| ASNB:US | $0.06 USD | -0.0162 |  |
| Company | Last | Change | |
| No competitor information is available for ASNB. | |||
| View Industry Companies | |||
Industry Analysis
ASNB
Industry Average
| Valuation | ASNB | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 0.6x |
|
| Price/Book | 1.3x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | NM | Not Meaningful |
Post a JobJobs
- Orlando, FL | Consult SoftPosted: May 22
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
Sponsored Financial Commentaries
Sponsored Links
To contact ADVANSOURCE BIOMATERIALS COR, please visit www.advbiomaterials.com. Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
